title: Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
authors.affiliation: Behçet's Disease Unit, Rheumatology Research Center, Tehran University for Medical Sciences, Shariati Hospital, Tehran, Iran.
authors.forename: F
authors.initials: F
authors.lastname: Shahram
authors.forename: F
authors.initials: F
authors.lastname: Davatchi
authors.forename: H
authors.initials: H
authors.lastname: Chams
authors.forename: A
authors.initials: A
authors.lastname: Nadji
authors.forename: A
authors.initials: A
authors.lastname: Jamshidi
authors.forename: M
authors.initials: M
authors.lastname: Akbarian
authors.forename: F
authors.initials: F
authors.lastname: Gharibdoost
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D031300:Retinal Vasculitis / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D014606:Uveitis, Anterior / Q000188:drug therapy* / Q000209:etiology; D015866:Uveitis, Posterior / Q000188:drug therapy* / Q000209:etiology; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine